Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.

Authors

Dee Anna Glaser
Adelaide A Hebert
Alexander Nast
William P Werschler
Lawrence Green, George Washington University
Richard Mamelok
Janice Drew
John Quiring
David M Pariser

Document Type

Journal Article

Publication Date

7-10-2018

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2018.07.002

Comments

epub ahead of print

APA Citation

Glaser, D., Hebert, A., Nast, A., Werschler, W., Green, L., Mamelok, R., Drew, J., Quiring, J., & Pariser, D. (2018). Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.. Journal of the American Academy of Dermatology, (). http://dx.doi.org/10.1016/j.jaad.2018.07.002

Peer Reviewed

1